[{"orgOrder":0,"company":"Wanbury Limited","sponsor":"Cipla","pharmaFlowCategory":"D","therapeuticArea":"Hematology","country":"INDIA","productType":"Small molecule","year":"2020","type":"Acquisition","leadProduct":"Folic Acid","moa":"","graph1":"Hematology","graph2":"Approved","graph3":"Wanbury Limited","amount2":0.01,"highestDevelopmentShortName":"Approved","therapeuticAreaShortName":"Hematology","amount2New":0.01,"dosageForm":"Tablet","sponsorNew":"Wanbury Limited \/ Cipla","highestDevelopmentStatusID":"12","companyTruncated":"Wanbury Limited \/ Cipla"},{"orgOrder":0,"company":"Danone","sponsor":"Not Applicable","pharmaFlowCategory":"DU","therapeuticArea":"Hematology","country":"FRANCE","productType":"Small molecule","year":"2022","type":"Not Applicable","leadProduct":"Iron","moa":"","graph1":"Hematology","graph2":"Approved","graph3":"Danone","amount2":0,"highestDevelopmentShortName":"Approved","therapeuticAreaShortName":"Hematology","amount2New":0,"dosageForm":"Dry Powder","sponsorNew":"Danone \/ Not Applicable","highestDevelopmentStatusID":"12","companyTruncated":"Danone \/ Not Applicable"}]

Find Clinical Drug Pipeline Developments & Deals for Iron

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
filter

Year

filter

DEALS // DEV.

filter

Country

filter
Sponsor
filter

Therapeutic Area

filter

Study Phase

filter

Deal Type

filter

Product Type

filter

Dosage Form

filter

Lead Product

filter

Target

Therapeutic Area by Lead Product

ForexGraph

Study Phase by Lead Product

ForexGraph

Company by Lead Product

ForexGraph

Top Deals by Deal Size (USD bn)

ForexGraph

01

Pharma, Lab & Chemical Expo
Not Confirmed
Pharma, Lab & Chemical Expo
Not Confirmed

Details : Aptamil (Iron) First Infant Milk Stage 1(This infant formula is appropriate for most infants and meets U.S. nutrient requirements, but it may not be suitable for infants born prematurely, or with a low birth weight.

Brand Name : Aptamil

Molecule Type : Small molecule

Upfront Cash : Not Applicable

June 17, 2022

Lead Product(s) : Iron,DHA

Therapeutic Area : Hematology

Highest Development Status : Approved

Sponsor : Not Applicable

Deal Size : Not Applicable

Deal Type : Not Applicable

blank

02

Pharma, Lab & Chemical Expo
Not Confirmed
Pharma, Lab & Chemical Expo
Not Confirmed

Details : Cipla has acquired the four brands namely CPink, CDense, Productiv and Folinine to further strengthen its presence in the women's health segment, Cipla said in a filing to the BSE.

Brand Name : Undisclosed

Molecule Type : Small molecule

Upfront Cash : Undisclosed

February 07, 2020

Lead Product(s) : Folic Acid,Iron

Therapeutic Area : Hematology

Highest Development Status : Approved

Sponsor : Cipla

Deal Size : $12.3 million

Deal Type : Acquisition

blank